Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 9/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.40 |
| ▸ | TMPRSS6 | Q8IU80 | 4/20 | 0.39 |
| ▸ | PLAU | P00749 | 4/20 | 0.38 |
| ▸ | HPN | P05981 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.38 |
| ▸ | PLG | P00747 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7700495 | 0.92 | ITGB3 (0.47) | F2ITGB3ITGA2BTMPRSS6PLAU | |
| SCHEMBL7700493 | 0.92 | ITGB3 (0.47) | F2ITGB3ITGA2BTMPRSS6PLAU | |
| SCHEMBL7703837 | 0.88 | ALDH1A1 (0.45) | F2HPGD | |
| SCHEMBL7702556 | 0.87 | MAPT (0.41) | F2ITGB3ITGA2BTMPRSS6PLAU | |
| SCHEMBL7702564 | 0.87 | MAPT (0.41) | F2ITGB3ITGA2BTMPRSS6PLAU | |
| SCHEMBL7702509 | 0.84 | ITGB3 (0.48) | F2ITGB3ITGA2BF10 | |
| SCHEMBL7702515 | 0.84 | ITGB3 (0.48) | F2ITGB3ITGA2BF10 | |
| SCHEMBL7698698 | 0.81 | ITGB3 (0.40) | F2ITGB3ITGA2BTMPRSS6PLAU | |
| SCHEMBL7698702 | 0.81 | ITGB3 (0.40) | F2ITGB3ITGA2BTMPRSS6PLAU | |
| SCHEMBL7697141 | 0.79 | ITGB3 (0.45) | F2ITGB3ITGA2BTMPRSS6PLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6348504-B1 | COMPOUNDS WITH AMIDINE OR GUANIDINE GROUPS AND CARBOXY OR ESTER GROUPS THROMBOLYTICS AND/OR FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS. | DUPONT PHARMACEUTICALS COMPANY | 2002-02-19 | — | — | US | disclosed |